treatment initiation and adherence. Addressing these factors is critical if Canada is to meet the WHO's global call to eradicate TB in all low incidence settings. 1 Recent immigrants (70%) often originate from endemic TB zones, 2 and half are estimated to have LTBI. 1, 3 Canada's plans to increase immigration to 340 000 annually by 2020 could result in over 100 000 LTBI cases annually. With an estimated reactivation rate between 5% and 10%, 1, [3] [4] [5] and suboptimal current estimates of LTBI treatment completion rates (16% to 30%), 6 Canada could see 4000 new TB cases annually, potentially increasing annual TB expenditures to $280 to $559 M. 7 The WHO framework for the elimination of TB identifies three barriers to effective TB control: diminishing general awareness, diminishing political commitment, and diminishing clinical expertise. These system-level barriers inhibit strategic planning, surveillance, guideline development, forecasting, testing, quality control mechanisms, and the inclusion of LTBI in medical curricula. 8 While most low-incidence countries, like Canada, have general guidelines, only a few (England, for example) have a national TB strategy. 9, 10 Without a national strategy, TB and LTBI health care becomes fragmented, resulting in suboptimal TB diagnosis and treatment and a greater risk of TB reactivation, progression, and transmission. 11 The risk of TB reactivation from LTBI can be mitigated, assuming no further exposure, by completing LTBI treatment. In Canada, LTBI treatment is provided without direct cost to clients. However, LTBI treatment initiation and completion rates are suboptimal. 4, 6, [12] [13] [14] Most research has focused on patient-level barriers to treatment initiation and completion, 3, 12, 13, [15] [16] [17] [18] [19] [20] [21] and less attention has been given to the factors at the policy and planning stage. This study investigated the system-level barriers to LTBI treatment for immigrant populations in the Greater Toronto and Hamilton Area (GTHA), Canada. • Health literacy of patients
• Screening
• Challenges with delivering LTBI treatment
• High risk and hard to treat population
• Barriers for LTBI treatment adherence
• Resources needs
• Perceptions of facilitators of LTBI adherence
Clients
• Understanding of LTBI diagnosis, treatment, treatment risks and personal risk of reactivation
• Value placed on treatment
• Perception of facilitators of LTBI adherence of an initial coding scheme, along with themes identified from a literature review. 8 The coding scheme included 11 parent nodes and 23 child nodes ( Figure 1 ). As analysis progressed, definitions of nodes and concepts were modified to ensure they conveyed the meaning participants expressed in the interviews. The investigators met regularly to discuss and agree on the coding process, resolve transcoder discrepancies, and revise the coding scheme to ensure consistency in interviewing, coding, and interpretation of the data.
In the first stage of analysis, the data were analyzed according to the stakeholder group. The data were then triangulated to explore the different perspectives on each emergent theme. In the final phase, assumptions about the relationships within and between concepts, between concepts and demographic information, and within and between participant perspectives were explored. The full research team, which had expertise in public health, health economics, and the planning and delivery of LTBI care reviewed the results and provided feedback throughout the process. To further ensure that we had not misattributed concepts or comments of participants, the first draft of the full report was sent to the planner and providers who had participated in the study for comment and discussion.
3 | RESULTS
| Characteristics of participants
Thirty-two participants were recruited 10 planners, 13 providers, and 9 clients. Planners worked on TB or LTBI control from 2 to 25 years (median = 5). Three worked at a federal level, four at a provincial level, and three at a municipal level. Most were involved in advisory capacities that functioned across the health and public health systems. For providers, years providing LTBI care ranged from 1 to 34 years (median = 11). Providers included TB specialists; primary care (physicians, nurses, and nurse practitioners); and public health. The average age of clients was 44; four were female. Time in Canada ranged from 1 to 16 years, but most had been in Canada for more than 10 years. Three clients originated from Asia, five from Africa, and one from Eastern Europe. All clients spoke English as a second language, but two clients required an interpreter. 
| Low prioritization of LTB
Planners' statements indicated that LTBI management and treatment were a low priority. Statements included LTBI was not a reportable disease in Ontario (PL01 and PL02); other infectious diseases were a higher priority (PL05); and the return on investment for LTBI treatment was low because of poor completion rates (PL03).
A perception of LTBI as a low-priority health issue was evident in interviews from all three levels of governance in Canada.
… we don't systematically test all applicants [migrants intending to stay in Canada for more than … historically and to a big extent currently, TB is rarely on the provincial risk radar, and LTBI is definitely
not. (PL03)
One planner mentioned there were no provider incentives to screen for or treat LTBI (PL10). Another suggested providers may avoid screening because LTBI-positive patients were labor intensive to manage. There were mixed perspectives on whether LTBI should be given a higher priority given the low lifetime risk of reactivation. Several planners and providers also discussed the challenge of allocating resources to LTBI control in terms of the opportunity costs for other programs.
LTBI is not as big a priority for a bunch of reasons … if you have latent TB infection, you're well and there's no current public health risk for that condition. So, it gets difficult to pull resources from active TB cases, measles outbreaks, school vaccination programs where there might be a more imminent risk to either the person or the people around them and pull those into LTBI. (PL05)
However, despite the perception of a lower prioritization for LTBI at national and provincial levels, there was evidence that LTBI identification and treatment were prioritized in some locales. Participants discussed the critical FIGURE 2 Relationship between study themes. LTBI, latent tuberculosis infection role of local providers and/or public health units in driving this, most often occurring in areas with existing LTBI experience associated with their larger migrant populations.
… we've actually shifted around some of our resources to be able to increase our calls to our LTBI clients.
We had low rates of treatment completion, and that just wasn't acceptable to us, given that reducing the LTBI reservoir is a main drive in decreasing active cases. (PL06)
But the extent to which this could be done effectively was constrained by available resources for LTBI. For example, one provider discussed the cost of the tuberculin skin test (TST) as a barrier for screening their migrant populations:
… There's been recent restriction on the Tubersol … this has kind of put the brakes on a lot of testing for … either active or latent TB Infection. And that's a bit of a barrier. (PR03)
Most providers and planners believed LTBI treatment was a low priority for clients due to a number of competing priorities such as finding work, English classes, and childcare. However, in contrast, clients stated LTBI treatment was a high priority, because they valued their own health and the health of their family. 
| LTBI management
Some planners and providers expressed concerns that LTBI screening may not be targeting the "right" people (PL05, PR02, and PR07).
The bigger issue is who we even screen for LTBI … We both over-screen and under-screen. We screen way too many Canadian born people at, essentially, zero risk who are in settings where the risk is also negligible.
And we under-screen people who could really benefit, which is largely newcomers to Canada from high-
burden TB communities. (PL05)
While planners acknowledged that LTBI screening often occurred opportunistically, some felt enhanced screening may not add value.
there is definitely a gap that exists within the screening and surveillance piece [with] a lot of testing done very opportunistically … but I wonder if we should be concerned about that. We know about 5-10% of LTBI cases will go on to develop active disease. And we have good processes in place for catching that
…. (PL03)
Planners and providers indicated they would benefit from a better understanding of the risk factors for reactivation and the reasons behind noncompliance but data quantity and quality gaps at all levels of governance were impediments.
We At the federal level, the lack of feedback and information sharing between the various levels of authority was thought to limit opportunities to trace the origins of active TB cases and investigate potential integrity issues related to the immigration medical screening program, which limited the government's ability to evaluate the effectiveness of broader LTBI control strategies and immigration policies.
Several providers stated the lack of feedback from public health units also hindered opportunities to evaluate program performance (PR02 and PR12).
Like, I'm curious what [is] the [LTBI treatment] completion rate [of this service] … Cause in my mind I think
that I complete 100% of people, but I'm sure I don't. (PR02)
| Service delivery
A recurring theme was the impact of a decentralized pubic health care system and its contribution to fragmented LTBI management (PL01, PL04, PL05, and PR13).
Tuberculosis care in Canada is, to be polite, extremely fragmented. There's really no concerted national strategy for the management of LTBI. And then we don't have good cross-talk between our health authorities and other countries' health authorities … We don't have a network of TB treaters where everybody's plugged in and knows each other or has a common platform of tools or a common toolbox
… We don't have a centralised database. We don't have a national registry …. (PR13)
Some providers had access to multilanguage client teaching materials, while others did not have such access.
Some clinics diagnosed clients using the TST and chest X-ray, while others used the interferon-gamma release assay (IGRA) test. Some providers treated all positive clients, while others only treated clients based on risk factors or positive IGRA tests. Some low-risk clients received LTBI services at TB specialist clinics, while others received LTBI services at primary care clinics, or walk-in clinics. Fragmentation may also have resulted in duplication and the inefficient use of resources. One planner mentioned that their work group was developing a risk assessment tool, while another provider stated that they were already using such a tool.
3.5 | Health care access: availability, acceptability, and affordability of LTBI care
There were mixed perspectives on the availability of LTBI services. Some clients felt that TB clinics were very accommodating, and it was easy to make appointments, but one questioned why care could not be continued through their family physician. Two clients found the clinic locations problematic, and one found clinic hours restrictive.
Some providers and planners questioned acceptability of the TST due to the potential for false-positive results and interpretation errors. A false-positive TST can be caused by non-tuberculous mycobacterial infection or previous BCG vaccinations.
I think skin tests have a lot of problems, so I only trust a skin test from our nurses here, read by people here, that they're actually well done … over the last year and a half, Gamma Interferon has been a total lifesaver, we've had a lot of negatives … these are all people that we would have treated. (PR02)
Providers, planners, and clients agreed that the treatment duration (9 months) was a substantial barrier and that a shorter regimen would help to increase completion rates.
… If you can have shorter treatment, I think more people would comply. (PL06)
One provider viewed LTBI treatment unacceptable for clients who were at high risk of reexposure. Nonmedical costs were discussed by most clients as posing an affordability barrier to treatment adherence.
These included clinic parking costs, time costs, and work loss associated with follow-up.
| Health literacy
There was a low level of understanding of the disease course, treatment requirements, and risk factors among the clients. One client seemed unaware of their LTBI diagnosis, and one was unclear if LTBI was active TB or why certain tests were performed.
And they made it clear to me that it's not a disease; it's just protection. And down the road, if I take this medication, I will be free of so many other attacks like cancer, liver problems … or … with the bacteria in me now I am prone to any infection. But with the treatment it would help me to defeat some of these … illness down the road. (PT04)
Tuberculosis specialists reinforced this point.
It's one of the few diseases where I see … the most number of people don't know why the doctor sent them.
(PR13)
Planners and providers attributed poor understanding of LTBI among clients to misinformation conveyed by interpreters, varying levels of provider experience with and knowledge of LTBI and inadequate time to manage LTBI cases.
Providers discussed the challenge of overcoming normalization of LTBI among clients who had immigrated from TB endemic countries, as this was perceived to impact client receptiveness to accurate information about LTBI as well as the extent to which treatment was prioritized.
One of the things that I hear quite a bit is that everybody in my country has TB. (PR05)
Another LTBI provider stated that some clients believed the LTBI diagnosis was "made up," possibly to keep them out of Canada.
Misinformation, hearsay, and misconceptions were prevalent especially around BCG vaccination and TST for individuals from endemic countries.
so trying to explain that you probably test positive for latent TB infection because you've been exposed to somebody with TB. To get that message across versus you test positive not because of the BCG right so that is one of the barriers. (PR05)
Two clients stated they had not pursued LTBI treatment because they had been vaccinated for TB, and one was convinced that treatment was "undoing" the vaccination.
Nonetheless, clients stated they did not have difficulty understanding their providers, their diagnosis, or treatment and did not require additional information.
Finally, issues of health literacy also extended to providers. Two providers stated that LTBI had not been part of their formal medical training and this impacted their level of expertise to treat LTBI. One participant discussed the burden faced by TB specialists because providers inexperienced with managing LTBI frequently referred LTBI clients to specialist clinics.
… I was trying to go through the process of teaching myself a little bit about how to interpret the TB skin test and playing around with the tool, there was a lot of stuff there in terms of risk factors that I hadn't even known about that wasn't explicitly taught to us during our education …. (PR06)
| DISCUSSION
WHO has expressed concerns that high-income countries have become complacent with respect to TB control 8 and there is evidence of this in Canada due to the low prioritization of LTBI treatment and control.
Previous studies have reported client-level barriers to LTBI treatment initiation and completion such as socioeconomic characteristics, language, and culture. While we found these factors play a role, our primary finding was the important role of upstream system-level 3, 8, 13 screening for all migrants from endemic countries, 9,10 and others are considering a similar policy. 22 Inequity also stems from quality of care. Some clients were diagnosed with a TST, while others were diagnosed using the IGRA test. Although both tests are used to diagnose LTBI, IGRA is preferred for those with a previous BCG vaccine. 1, 23 Some providers in our sample did not support LTBI treatment unless TST results were confirmed by the IGRA test due to the potential for false positives. Evidence supports clients are more likely to follow through with LTBI treatment if they have been diagnosed through the IGRA blood test rather than TST. 24 Interferon-gamma release assay testing has also been shown to be cost-effective when compared with usual care. 25 Clients receiving LTBI care from TB specialists were more likely to receive the 4-month rifampin protocol rather than the 9-month isoniazid. Planners, providers, and clients agreed that a shorter treatment duration would improve LTBI treatment initiation and completion, and this is supported by the literature. 14,27,28 Furthermore, one specialist questioned the appropriateness of treating clients that are at high risk of reexposure such as those who regularly traveled to endemic countries.
Another inequity faced by LTBI clients was the out-of-pocket costs. Some of these costs were the result of restrictions placed on the aspartate transaminase liver enzyme test by provincial health insurance. An alternative test, alanine aminotransferase remains fully covered. 29 The variations in access to TST tests without cost may be explained by different interpretations of the medically necessary criteria applied to public coverage of TST. 29 And some patients faced a $90 out-of-pocket cost for the IGRA test not covered by OHIP. All the inconsistencies mentioned above have resulted in migrants being treated differently depending on their place of residence or source of health care.
The final upstream barrier was data collection and management. Planners at all three levels of governance described the pervasive impact of data problems. There is a symbiotic relationship between data collection and priority setting. It is difficult to determine the degree to which LTBI treatment should be a priority because high-risk immigrant populations are not screened at point of entry and exact numbers affected by LTBI is unknown. We estimate potentially 4000 new cases of active TB annually. England recently began systematic screening of high-risk immigrant groups because of a spike in TB cases. 10 Data gaps have also affected planners' and providers' ability to develop advanced risk factor instruments, self-regulate performance, share information, and address potential cases of fraudulent medical exams as part of immigration applications.
The study was conducted in the GTHA where planners and providers have experience with LTBI due to large immigrant populations, but where approaches to LTBI care differ. One of the areas has a centralized approach with services delivered through specialty clinics, while the other two delivered LTBI care in a variety of settings (private clinics, community clinics, and specialty services). Participants were recruited until content saturation was reached;
however, participants self-selected into the study, which could have introduced selection bias. Because we used snowball approaches to recruitment, there is the potential that the participants who were recommended to the study supported a particular bias. By recruiting from a range of sources, provincial and federal government, public health agencies, private clinics, community clinics, and specialty clinics, any potential biases should be minimal.
| CONCLUSION
The study shows how upstream system-level barriers such as prioritization, fragmentation, and the lack of a federal TB strategy can impact LTBI control; patient and provider knowledge and behavior; and, ultimately, initiation and completion of LTBI treatment by patients. We highlighted several sources of inequities that exist within the health care and public health systems in Ontario that may be functioning to disadvantage individuals with LTBI. Addressing these inequities should be prioritized and is critical if Canada is to meet the WHO's global call to eradicate TB in all low incidence settings by 2035.
